BioCentury
ARTICLE | Clinical News

LB03002: Phase III data

October 10, 2011 7:00 AM UTC

An open-label, international Phase III trial in 167 previously untreated children with GHD showed that expected height velocity growth rates were maintained during the second year of treatment in pati...